BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
Top Cited Papers
Open Access
- 1 January 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 34 (5) , 1416-1426
- https://doi.org/10.1093/nar/gkl010
Abstract
Germline mutations of the breast cancer associated gene 1 (BRCA1) predispose women to breast and ovarian cancers. BRCA1 is a large protein with multiple functional domains and interacts with numerous proteins that are involved in many important biological processes/pathways. Mounting evidence indicates that BRCA1 is involved in all phases of the cell cycle and regulates orderly events during cell cycle progression. BRCA1 deficiency, consequently causes abnormalities in the S-phase checkpoint, the G2/M checkpoint, the spindle checkpoint and centrosome duplication. The genetic instability caused by BRCA1 deficiency, however, also triggers cellular responses to DNA damage that blocks cell proliferation and induces apoptosis. Thus BRCA1 mutant cells cannot develop further into full-grown tumors unless this cellular defense is broken. Functional analysis of BRCA1 in cell cycle checkpoints, genome integrity, DNA damage response (DDR) and tumor evolution should benefit our understanding of the mechanisms underlying BRCA1 associated tumorigenesis, as well as the development of therapeutic approaches for this lethal disease.Keywords
This publication has 101 references indexed in Scilit:
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Intrinsic tumour suppressionNature, 2004
- Identification of BRCA1-IRIS, a BRCA1 locus productNature Cell Biology, 2004
- Aurora kinases in spindle assembly and chromosome segregationExperimental Cell Research, 2004
- Cell Cycle Differences in DNA Damage-induced BRCA1 Phosphorylation Affect Its Subcellular LocalizationJournal of Biological Chemistry, 2003
- Roles of BRCA1 in centrosome duplicationOncogene, 2002
- A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancersThe EMBO Journal, 1998
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996